STATE OF INTESTINAL MICROBIOTA IN TYPE 2 DIABETES AND OBESITY

Шагазатова Барно Хабибуллаевна, Вафоев Шахзод Фарход уғли, Мирхайдарова Феруза Сайфуллаевна

Марказий Осиё эндокринологик журнали · 2024-yil

Annotatsiya

The role of intestinal microbiota in the development and prevention of metabolic dysfunctions is increasing. The symbiotic relationship between the intestinal microbiota and the body ensures the proper development of the human metabolic system. At the same time, disturbances in the composition and, in turn, functionality of the intestinal microbiota can disrupt the function of the intestinal barrier and subsequently serve as a switch for metabolic endotoxemia. Chronic inflammation, caused by the entry of bacterial particles into the bloodstream through disruption of the intestinal barrier, has a significant impact on the accumulation of body fat and the development of insulin resistance. Recent evidence suggests that some bacteria influence the endocannabinoid system outside the gastrointestinal tract, mediated by gut hormones and metabolites from other systems. When the numbers of certain bacterial species begin to decline, the symbiosis is disrupted, leading to deterioration in the host's metabolic health. This article describes the complex axis between the microbiota and host metabolism.

Maqola ma’lumotlari
MualliflarШагазатова Барно Хабибуллаевна, Вафоев Шахзод Фарход уғли, Мирхайдарова Феруза Сайфуллаевна
JurnalМарказий Осиё эндокринологик журнали
Nashr sanasi2024-11-06
Jild4
Son2
TilO‘zbek

Kalit so‘zlar

Микробиота; симбиоз, инсулинрезистентность, короткоцепочечные жирные кислоты, ожирение, Microbiota, symbiosis, insulinresistence, short-chain fatty acids, obesity, Mikrobita, simbioz, insulinrezistenlik, qisqa zanjirli yog’ kislotalari, semizlik

Ilmiy soha

Марказий Осиё эндокринологик журнали jurnalidan boshqa maqolalar

Марказий Осиё эндокринологик журнали — barcha maqolalar